Beijing Strong Biotechnologies,Inc. (SHE:300406)
China flag China · Delayed Price · Currency is CNY
11.85
+0.13 (1.11%)
Sep 1, 2026, 3:04 PM CST

SHE:300406 Cash Flow Statement

Millions CNY. Fiscal year is Jan - Dec.

Operating Activities

Fiscal Year
TTMFY 2025FY 2024FY 2023FY 2022FY 2021
Period Ending
Jun '26 Dec '25 Dec '24 Dec '23 Dec '22 Jan '22
Net Income
224.98189.87538.29523.74389.1405.65
Depreciation & Amortization
70.969.427156.2154.8243.62
Other Amortization
1.852.681.170.960.881.87
Loss (Gain) From Sale of Assets
2.472.872.113.52.68-0.16
Asset Writedown & Restructuring Costs
194.17175.61.380.215.320.11
Loss (Gain) From Sale of Investments
-20.21-12.14-9.61-20.76-19.08-11.53
Provision & Write-off of Bad Debts
14.426.353.3923.4439.1537.13
Other Operating Activities
57.3656.7148.0452.1760.2383.8
Change in Accounts Receivable
25.52100.0715.81-69.02-84.94-184.23
Change in Inventory
14.2620.9-16.2-13.21-11.24-31.01
Change in Accounts Payable
-2.17-57.58-31.8837.36-33.218.5
Operating Cash Flow
567.83565.11614.01585.09396.17341.1
Operating Cash Flow Growth
-10.67%-7.96%4.94%47.69%16.14%177.18%

Investing Activities

Fiscal Year
TTMFY 2025FY 2024FY 2023FY 2022FY 2021
Period Ending
Jun '26 Dec '25 Dec '24 Dec '23 Dec '22 Jan '22
Capital Expenditures
-26.63-39.24-67.65-148.03-96.48-65.2
Sale of Property, Plant & Equipment
-0.040.060.211.03-0.23
Cash Acquisitions
-----1.44-
Investment in Securities
-45.47-386.71-73.2815-341.28-1,256
Other Investing Activities
-62.8-49.43122.14.79-1.638.9
Investing Cash Flow
-134.94-475.32-18.62-127.21-440.82-1,312

Financing Activities

Fiscal Year
TTMFY 2025FY 2024FY 2023FY 2022FY 2021
Period Ending
Jun '26 Dec '25 Dec '24 Dec '23 Dec '22 Jan '22
Long-Term Debt Issued
-1.3223.2106.591,2901,122
Long-Term Debt Repaid
--129.35-33.48-104.44-1,154-302.34
Net Debt Issued (Repaid)
-110.88-128.04-10.282.15136.16819.94
Issuance of Common Stock
--3.2137.09-37.33
Repurchase of Common Stock
--18.79-44.66-49.45-51.1-
Common Dividends Paid
-716.41-537.14-124.19-64.66-90.65-78.61
Other Financing Activities
-0.943.15-0.550.12-4.99-1.98
Financing Cash Flow
-828.23-680.81-176.48-74.76-10.58776.67

Net Cash Flow

Fiscal Year
TTMFY 2025FY 2024FY 2023FY 2022FY 2021
Period Ending
Jun '26 Dec '25 Dec '24 Dec '23 Dec '22 Jan '22
Foreign Exchange Rate Adjustments
-0.73-0.390.520.21.03-0.36
Net Cash Flow
-396.07-591.41419.43383.32-54.21-194.67

Free Cash Flow

Fiscal Year
TTMFY 2025FY 2024FY 2023FY 2022FY 2021
Period Ending
Jun '26 Dec '25 Dec '24 Dec '23 Dec '22 Jan '22
Free Cash Flow
541.2525.87546.36437.06299.69275.9
Free Cash Flow Growth
-8.76%-3.75%25.01%45.84%8.63%160.74%
Free Cash Flow Margin
39.62%38.80%32.93%25.09%19.84%17.25%
Free Cash Flow Per Share
0.910.890.910.730.490.47
Levered Free Cash Flow
154.98309.84338293.07157.06211.82
Unlevered Free Cash Flow
171340.74367.75322.44189.96225.32

Additional Metrics

Fiscal Year
TTMFY 2025FY 2024FY 2023FY 2022FY 2021
Period Ending
Jun '26 Dec '25 Dec '24 Dec '23 Dec '22 Jan '22
Cash Income Tax Paid
206.33197.68197.19189.57162.92165.81
Change in Working Capital
21.9153.72-41.76-54.37-136.93-219.38